Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
U8tub9NakY8TMvKu